Small is beautiful: insulin-like growth factors and their role in growth, development, and cancer

Robert G Maki1

  • 1Memorial Sloan-Kettering Cancer Center, New York, NY 10065-6007, USA. makir@mskcc.org

Insights

Insulin-like growth factors (IGFs) are key to growth and development. New therapies targeting IGF-1 receptor show promise for cancer treatment, especially when combined with other pathway inhibitors.

Area of Science:

  • Endocrinology
  • Oncology
  • Molecular Biology

Background:

  • Insulin-like growth factors (IGFs) have long been recognized for their roles in growth and differentiation.
  • Interest in IGFs' role in cancer resurged with the development of targeted therapies.

Purpose of the Study:

  • To review the history and multifaceted roles of IGFs in biological processes and cancer.
  • To discuss recent clinical trials and future directions for IGF-targeting agents in oncology.

Main Methods:

  • Literature review of IGFs' historical significance and biological functions.
  • Analysis of recent Phase I-II clinical trial data for IGF-1 receptor inhibitors.
  • Exploration of combination therapy strategies for enhanced efficacy.

Main Results:

  • IGFs are crucial for growth, development, and survival, and are implicated in various cancers.
  • Early clinical trials of IGF-1 receptor inhibitors have yielded mixed results, with some showing limited efficacy.
  • Combination therapies targeting IGF signaling alongside other pathways show potential for improved outcomes.

Conclusions:

  • IGFs play a significant role in both normal physiology and oncogenesis.
  • Targeting the IGF-1 receptor presents a therapeutic avenue for cancer, but requires optimized strategies.
  • Future clinical success may depend on combining IGF inhibitors with agents targeting cross-resistant signaling pathways.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Cells Coordinate Growth and Proliferation02:36

Cells Coordinate Growth and Proliferation

Cell size is a significant factor impacting cellular design, function, and fitness. There exists some internal coordination by which cells double their masses before division, thus, achieving homeostasis. Coordination between cell growth and proliferation depends on the checkpoints in between cell cycle phases. Loss of coordination or failure in the checkpoint mechanism can drive the cell to uncontrolled growth and loss of cellular function. Like dividing cells that coordinate cellular growth,...
Cells Coordinate Growth and Proliferation02:36

Cells Coordinate Growth and Proliferation

Cell size is a significant factor impacting cellular design, function, and fitness. There exists some internal coordination by which cells double their masses before division, thus, achieving homeostasis. Coordination between cell growth and proliferation depends on the checkpoints in between cell cycle phases. Loss of coordination or failure in the checkpoint mechanism can drive the cell to uncontrolled growth and loss of cellular function. Like dividing cells that coordinate cellular growth,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...